• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. COMBISET ACCESS FLOW REVERSE CON TWISTER; ACCESSORIES, BLOOD CIRCUIT, HEMODIALYSIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. COMBISET ACCESS FLOW REVERSE CON TWISTER; ACCESSORIES, BLOOD CIRCUIT, HEMODIALYSIS Back to Search Results
Model Number 03-2794-0
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/01/2021
Event Type  malfunction  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
A hemodialysis (hd) facility administrator (fa) reported that a combi set blood leak occurred two to three minutes into a patient¿s hd treatment.The fa stated that the twister lines came apart where you twist the plastic piece that initiates the access flow.Some blood leaked onto the floor, and the separation was noticed almost immediately.The fa was unsure if there were any machine alarms.The patient was dialyzing on a fresenius 2008t machine and utilizing a fresenius optiflux dialyzer.There were no abnormal changes in pressure.Per the fa, the patient¿s blood flow rate was increased at a normal rate, to reach the prescribed blood flow rate.There were no visible defects found on the combi set prior to treatment, and there were no leaks during the priming phase.After the blood leak occurred, the treatment was paused.The patient¿s blood was not returned; estimated blood loss (ebl) was reportedly 300 ml.The fa confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The patient completed their treatment after being re-setup with new supplies on the same machine.The combi set was reported to be available for a manufacturer evaluation.
 
Manufacturer Narrative
Additional information: h3 plant investigation: although a sample was reported to be available for manufacturer evaluation, to date no sample has been received.A batch records review was conducted by the manufacturer for the reported lot.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.The entire lot has been sold and distributed.In addition, a device history review was performed and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The lot met all specifications for release.A product history review did not reveal a probable cause for the customer complaint.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.Should the sample be returned at a later date, a supplemental report will be submitted capturing the updated investigation results.
 
Event Description
A hemodialysis (hd) facility administrator (fa) reported that a combi set blood leak occurred two to three minutes into a patient¿s hd treatment.The fa stated that the twister lines came apart where you twist the plastic piece that initiates the access flow.Some blood leaked onto the floor, and the separation was noticed almost immediately.The fa was unsure if there were any machine alarms.The patient was dialyzing on a fresenius 2008t machine and utilizing a fresenius optiflux dialyzer.There were no abnormal changes in pressure.Per the fa, the patient¿s blood flow rate was increased at a normal rate, to reach the prescribed blood flow rate.There were no visible defects found on the combi set prior to treatment, and there were no leaks during the priming phase.After the blood leak occurred, the treatment was paused.The patient¿s blood was not returned; estimated blood loss (ebl) was reportedly 300 ml.The fa confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The patient completed their treatment after being re-setup with new supplies on the same machine.The combi set was reported to be available for a manufacturer evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMBISET ACCESS FLOW REVERSE CON TWISTER
Type of Device
ACCESSORIES, BLOOD CIRCUIT, HEMODIALYSIS
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
MDR Report Key12160864
MDR Text Key261461140
Report Number8030665-2021-01141
Device Sequence Number1
Product Code KOC
UDI-Device Identifier00840861100316
UDI-Public00840861100316
Combination Product (y/n)N
PMA/PMN Number
K022536
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup
Report Date 07/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2024
Device Model Number03-2794-0
Device Catalogue Number03-2794-0
Device Lot Number21BR01161
Was Device Available for Evaluation? Yes
Device AgeMO
Initial Date Manufacturer Received 07/01/2021
Initial Date FDA Received07/13/2021
Supplement Dates Manufacturer Received07/19/2021
Supplement Dates FDA Received07/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS OPTIFLUX DIALYZER; FRESENIUS OPTIFLUX DIALYZER
Patient Age76 YR
Patient Weight120
-
-